Werner Lanthaler
Director/Board Member en AC IMMUNE SA .
Fortuna: 24 M $ al 31/03/2024
Origen de la red de primer grado Werner Lanthaler.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
31
| Public Company | Pharmaceuticals: Major | 31 |
29
| Public Company | Pharmaceuticals: Major | 29 |
26
| Public Company | Pharmaceuticals: Other | 26 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria.
9
| Extinct | Pharmaceuticals: Major | 9 |
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Federation of Austrian Industry
 Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg.
2
| Non-Profit Organization | Miscellaneous Commercial Services | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Werner Lanthaler a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| SYMRISE AG | Chemicals: Specialty | Director/Board Member Director/Board Member | |
Cyprotex Discovery Ltd.
 Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The private company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Corporate Officer/Principal Corporate Officer/Principal Graduate Degree | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ACTIVE BIOTECH AB | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| École Polytechnique Fédérale de Lausanne | College/University | Graduate Degree Doctorate Degree | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of London | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| The University of Colorado | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
| IOMAI CORPORATION | Biotechnology | Founder Chief Executive Officer Director/Board Member | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member | |
| University of Zurich | College/University | Doctorate Degree Undergraduate Degree | |
| Ghent University | College/University | Graduate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
RAG-Stiftung
 RAG-Stiftung Investment Trusts/Mutual FundsMiscellaneous RAG-Stiftung operates as a private foundation. It provides financing services for the perpetual mine management as well as the educational, scientific, and cultural projects related to coal mining in the Ruhr and Saar regions. The company was founded on June 26, 2007 and is headquartered in Essen, Germany. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| SANA AB | Biotechnology | Chairman Founder | |
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The private company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The private company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Chairman Director/Board Member | |
| TME PHARMA N.V. | Biotechnology | Chairman Director/Board Member | |
Aptuit (Oxford) Ltd.
 Aptuit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Part of Evotec SE, Aptuit (Oxford) Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Abingdon, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The private company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Miscellaneous Commercial Services | Chairman Chairman |
Estadísticas
Internacional
| Estados Unidos | 14 |
| Alemania | 11 |
| Suiza | 9 |
| Dinamarca | 6 |
| Reino Unido | 5 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 16 |
| Commercial Services | 6 |
| Process Industries | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 598 |
| Corporate Officer/Principal | 231 |
| Chairman | 189 |
| Independent Dir/Board Member | 139 |
| Chief Executive Officer | 101 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Roland Sackers | 78 |
| Paul Sekhri | 62 |
| Friedrich von Bohlen und Halbach | 36 |
| Corey Goodman | 35 |
| Joseph deBethizy | 29 |
| Michel Gréco | 28 |
| Claus Tycho Bræstrup | 27 |
| Alan Colowick | 27 |
| David Ebsworth | 26 |
| Michael Shalmi | 25 |
| Monika Bütler | 25 |
| Colin Bond | 25 |
| Douglas Williams | 25 |
| Kari Kapsch | 24 |
| James Sulat | 23 |
- Bolsa de valores
- Insiders
- Werner Lanthaler
- Conexiones Empresas
